EBITDA Summary of AstraZeneca PLC

AstraZeneca PLC's latest annual EBITDA in 2023 was 13.42 Billion USD , up 49.15% from previous year.
AstraZeneca PLC's latest quarterly EBITDA in 2024 Q2 was 4.11 Billion USD , down -9.77% from previous quarter.
AstraZeneca PLC reported an annual EBITDA of 9.08 Billion USD in 2022, up 23.29% from previous year.
AstraZeneca PLC reported an annual EBITDA of 5.11 Billion USD in 2021, down -9.63% from previous year.
AstraZeneca PLC reported a quarterly EBITDA of 4.46 Billion USD for 2024 Q1, up 109.5% from previous quarter.
AstraZeneca PLC reported a quarterly EBITDA of N/A for 2023 FY, up 49.15% from previous quarter.

Annual EBITDA Chart of AstraZeneca PLC (2023 - 1990)

Historical Annual EBITDA of AstraZeneca PLC (2023 - 1990)

Year	EBITDA	EBITDA Growth
2023	13.42 Billion USD	49.15%
2022	9.08 Billion USD	23.29%
2021	5.11 Billion USD	-9.63%
2020	8.08 Billion USD	19.31%
2019	6.71 Billion USD	-2.08%
2018	7.11 Billion USD	5.82%
2017	6.62 Billion USD	-7.16%
2016	7.27 Billion USD	4.25%
2015	6.96 Billion USD	27.41%
2014	5.49 Billion USD	-34.2%
2013	8.34 Billion USD	-25.45%
2012	10.68 Billion USD	-22.34%
2011	15.38 Billion USD	-2.28%
2010	14.74 Billion USD	4.68%
2009	13.94 Billion USD	8.19%
2008	12.61 Billion USD	9.68%
2007	9.95 Billion USD	13.65%
2006	9.56 Billion USD	23.02%
2005	7.82 Billion USD	33.83%
2004	5.81 Billion USD	15.57%
2003	5.3 Billion USD	2.66%
2002	4.96 Billion USD	-28.55%
2001	5.01 Billion USD	30.91%
2000	4.91 Billion USD	8.69%
1999	4.49 Billion USD	119.23%
1998	3.24 Billion USD	5.9%
1997	2.24 Billion USD	1.49%
1996	2.15 Billion USD	27.44%
1995	1.35 Billion USD	6.85%
1994	1.47 Billion USD	19.6%
1993	1.37 Billion USD	14.01%
1992	687.06 Million USD	-28.02%
1991	1.67 Billion USD	22.21%
1990	1.37 Billion USD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	4.11 Billion USD	-9.77%
2024 Q1	4.46 Billion USD	109.5%
2023 FY	- USD	49.15%
2023 Q1	3.88 Billion USD	241.65%
2023 Q2	2.51 Billion USD	-35.21%
2023 Q3	3.32 Billion USD	32.04%
2023 Q4	2.9 Billion USD	-12.54%
2022 Q4	1.13 Billion USD	-58.75%
2022 Q1	2.19 Billion USD	832.67%
2022 FY	- USD	23.29%
2022 Q2	1.91 Billion USD	-12.88%
2022 Q3	2.75 Billion USD	44.07%
2021 Q1	2.7 Billion USD	81.99%
2021 Q3	1.46 Billion USD	-20.4%
2021 Q2	1.84 Billion USD	-31.94%
2021 Q4	-300 Million USD	-120.45%
2021 FY	- USD	-9.63%
2020 Q2	2 Billion USD	-5.12%
2020 Q3	2.12 Billion USD	6.45%
2020 Q4	1.48 Billion USD	-30.11%
2020 FY	- USD	19.31%
2020 Q1	2.1 Billion USD	231.45%
2019 Q1	1.8 Billion USD	68.79%
2019 Q3	1.53 Billion USD	24.74%
2019 FY	- USD	-2.08%
2019 Q4	636 Million USD	-58.51%
2019 Q2	1.22 Billion USD	-31.76%
2018 Q2	1.47 Billion USD	3.16%
2018 FY	- USD	5.82%
2018 Q4	1.06 Billion USD	-30.67%
2018 Q3	1.53 Billion USD	4.62%
2018 Q1	1.42 Billion USD	97.23%
2017 Q2	1.55 Billion USD	-1.52%
2017 Q3	1.81 Billion USD	16.9%
2017 Q4	723 Million USD	-60.25%
2017 FY	- USD	-7.16%
2017 Q1	1.58 Billion USD	-37.92%
2016 Q1	1.61 Billion USD	47.81%
2016 FY	- USD	4.25%
2016 Q3	1.64 Billion USD	82.65%
2016 Q4	2.54 Billion USD	54.99%
2016 Q2	899 Million USD	-44.4%
2015 FY	- USD	27.41%
2015 Q3	1.74 Billion USD	5.94%
2015 Q1	1.78 Billion USD	658.75%
2015 Q2	1.65 Billion USD	-7.72%
2015 Q4	1.09 Billion USD	-37.41%
2014 FY	- USD	-34.2%
2014 Q1	1.56 Billion USD	370.42%
2014 Q3	1.4 Billion USD	-22.45%
2014 Q4	-320 Million USD	-122.71%
2014 Q2	1.81 Billion USD	16.25%
2013 Q3	2.1 Billion USD	-1.77%
2013 Q2	2.14 Billion USD	3.67%
2013 Q1	2.07 Billion USD	-1.52%
2013 FY	- USD	-25.45%
2013 Q4	-578 Million USD	-127.42%
2012 Q1	2.79 Billion USD	21.72%
2012 FY	- USD	-22.34%
2012 Q3	3.03 Billion USD	20.86%
2012 Q2	2.5 Billion USD	-10.18%
2012 Q4	2.1 Billion USD	-30.63%
2011 Q1	4.06 Billion USD	5.64%
2011 Q2	3.61 Billion USD	-11.12%
2011 Q3	4.95 Billion USD	37.26%
2011 Q4	2.29 Billion USD	-53.75%
2011 FY	- USD	-2.28%
2010 Q1	4.17 Billion USD	29.32%
2010 Q4	3.84 Billion USD	22.87%
2010 FY	- USD	4.68%
2010 Q3	3.13 Billion USD	-12.81%
2010 Q2	3.59 Billion USD	-14.03%
2009 Q1	3.66 Billion USD	420.77%
2009 Q4	3.23 Billion USD	-14.82%
2009 Q2	3.4 Billion USD	-6.88%
2009 Q3	3.79 Billion USD	11.23%
2009 FY	- USD	8.19%
2008 Q1	3.33 Billion USD	2264.94%
2008 FY	- USD	9.68%
2008 Q4	703 Million USD	-78.67%
2008 Q3	3.29 Billion USD	2.71%
2008 Q2	3.2 Billion USD	-3.75%
2007 Q2	2.95 Billion USD	3.07%
2007 Q3	2.95 Billion USD	-0.24%
2007 Q4	-154 Million USD	-105.22%
2007 FY	- USD	13.65%
2007 Q1	2.86 Billion USD	122.58%
2006 Q3	2.65 Billion USD	0.72%
2006 Q1	2.45 Billion USD	81.67%
2006 FY	- USD	23.02%
2006 Q4	1.28 Billion USD	-51.47%
2006 Q2	2.63 Billion USD	7.28%
2005 Q3	2.41 Billion USD	21.88%
2005 Q4	1.35 Billion USD	-44.04%
2005 Q1	1.88 Billion USD	156.9%
2005 FY	- USD	33.83%
2005 Q2	1.98 Billion USD	5.48%
2004 Q1	1.38 Billion USD	43.48%
2004 Q4	-3.3 Billion USD	-371.65%
2004 FY	- USD	15.57%
2004 Q3	1.21 Billion USD	-2.33%
2004 Q2	1.24 Billion USD	-10.1%
2003 Q4	1.16 Billion USD	-39.42%
2003 Q2	1.07 Billion USD	-31.69%
2003 Q1	1.56 Billion USD	116.28%
2003 Q3	1.59 Billion USD	48.93%
2003 FY	- USD	2.66%
2002 Q2	1.29 Billion USD	-19.65%
2002 FY	- USD	-28.55%
2002 Q4	968.8 Million USD	-36.36%
2002 Q3	1.13 Billion USD	-8.39%
2002 Q1	1.52 Billion USD	-59.16%
2001 Q3	1.22 Billion USD	0.54%
2001 Q2	1.15 Billion USD	-9.9%
2001 Q1	1.3 Billion USD	-38.4%
2001 FY	- USD	30.91%
2001 Q4	3.44 Billion USD	223.51%
2000 Q3	1.18 Billion USD	-4.26%
2000 Q1	1.19 Billion USD	-29.21%
2000 FY	- USD	8.69%
2000 Q4	1.29 Billion USD	76.8%
2000 Q2	1.23 Billion USD	3.89%
1999 Q2	1.26 Billion USD	-73.12%
1999 Q3	1.16 Billion USD	-5.8%
1999 Q4	-584.53 Million USD	47.24%
1999 Q1	4.52 Billion USD	183.46%
1999 FY	- USD	119.23%
1998 Q2	869 Million USD	-77.66%
1998 FY	- USD	5.9%
1998 Q4	-5.41 Billion USD	-332.5%
1998 Q1	2.41 Billion USD	154.81%
1998 Q3	2.33 Billion USD	331.52%
1997 Q2	2.28 Billion USD	0.0%
1997 Q4	-4.41 Billion USD	-310.08%
1997 Q3	2.09 Billion USD	-8.08%
1997 Q1	2.28 Billion USD	180.2%
1997 FY	- USD	1.49%
1996 Q2	2.27 Billion USD	0.0%
1996 Q3	2.31 Billion USD	1.54%
1996 Q4	-2.84 Billion USD	-223.09%
1996 FY	- USD	27.44%
1996 Q1	2.27 Billion USD	147.94%
1995 Q2	346 Million USD	-82.85%
1995 Q4	-4.75 Billion USD	-345.61%
1995 FY	- USD	6.85%
1995 Q3	1.93 Billion USD	459.25%
1995 Q1	2.01 Billion USD	150.05%
1994 Q4	-4.02 Billion USD	-329.91%
1994 Q2	1.83 Billion USD	0.0%
1994 FY	- USD	19.6%
1994 Q1	1.83 Billion USD	147.16%
1994 Q3	1.75 Billion USD	-4.57%
1993 Q1	1.74 Billion USD	0.0%
1993 Q2	1.74 Billion USD	0.0%
1993 Q3	1.53 Billion USD	-12.1%
1993 FY	- USD	14.01%
1993 Q4	-3.89 Billion USD	-353.42%
1992 FY	- USD	-28.02%
1991 FY	- USD	9.79%
1990 FY	- USD	0.0%

Peer EBITDA Comparison of AstraZeneca PLC

Name	EBITDA	EBITDA Difference
Lipidor AB (publ)	-10.62 Million SEK	126484.181%

Global Stocks Search

AstraZeneca PLC (AZN.ST)

EBITDA Summary of AstraZeneca PLC

Annual EBITDA Chart of AstraZeneca PLC (2023 - 1990)

Historical Annual EBITDA of AstraZeneca PLC (2023 - 1990)

Peer EBITDA Comparison of AstraZeneca PLC